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Abstract
The gram-negative bacterium Coxiella burnetii causes human Q fever, a disease characterized by a 
debilitating flu-like illness in acute cases and endocarditis in chronic patients. An obligate 
intracellular pathogen, Coxiella burnetii survives within a large, lysosome-like vacuole inside the 
host cell. A unique feature of the Coxiella parasitophorous vacuole (PV) is high levels of fusion 
with the host endocytic pathway, with PV-endosome fusion critical for Coxiella survival within the 
host cell. This unit describes quantitating PV-endosome fusion by measuring delivery of the fluid 
phase endosome marker dextran to the PV using live cell imaging. To study the effect of host cell 
proteins involved in PV-endosome fusion, details are provided for using siRNA knockdown host 
cells. This method is a powerful tool to understanding mechanisms underlying Coxiella’s ability to 
manipulate host cell trafficking pathways.
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Introduction
The Coxiella parasitophorous vacuole (PV) is known to be highly fusogenic with host 
vesicular trafficking pathways, including endosomes, lysosomes, and autophagosomes 
(reviewed in (Larson et al., 2016)). In epithelial cells such as HeLa cells, the bacteria 
initially reside in a small, tight-fitting vacuole. Around 24–48 hours, the PV expands, 
followed by bacterial replication. While the source of membrane during PV expansion has 
not been definitively determined, it is believed to occur through fusion with endocytic 
vesicles. Further, Coxiella actively manipulates endocytic trafficking by secreting effector 
proteins into the host cytosol through the Coxiella type IVb secretion system (T4BSS). 
When PV-endosome fusion is inhibited through either depletion of host proteins involved in 
fusion or a Coxiella T4BSS mutant, Coxiella growth is significantly inhibited.
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Given the importance of PV-endosome fusion during Coxiella’s intracellular growth, the 
ability to examine PV-endosome fusion is critical to further understanding the dynamics of 
this interaction. Fluorescent dextran is internalized by fluid-phase endocytosis and known to 
be delivered to the PV (Heinzen, Scidmore, Rockey, & Hackstadt, 1996). This unit describes 
a method for quantitating trafficking of fluorescent dextran to the PV using confocal live cell 
microscopy (Basic Protocol 1). Support Protocols 1 and 2 describe Coxiella infection of 
HeLa cells and replating onto optical grade chambered slides. Supporting Protocol 3 uses 
siRNA to knockdown host genes of interest. Support Protocol 4 describes setup and testing 
of the live cell chamber, with data analysis provided in Support Protocol 5.
BASIC PROTOCOL 1. Trafficking of Fluid Phase Marker to the CPV
The basic principle of this protocol is a classic pulse-chase, where a fluorescent fluid phase 
marker (fluorescent dextran) is internalized by Coxiella-infected cells through endocytosis. 
After a pre-set time (or pulse), the fluid phase marker is removed from the media and the 
dextran-positive endosomes traffic and fuse with the PV (chase). The increase in PV dextran 
fluorescence is measured during the chase. The effect of depletion or overexpression of 
proteins, drug treatment, or bacterial mutant on dextran delivery to the PV can be measured 
to demonstrate a role in PV-endosome fusion.
This protocol uses wild type Coxiella burnetii expressing mCherry red fluorescent protein 
(mCherry-Coxiella) and the HeLa epithelial cell line. If other cell types are used, pulse-
chase conditions may need to be determined empirically. When using Coxiella strains not 
expressing mCherry, alternative methods will be needed to identify PVs (e.g., phase 
microscopy). This protocol uses an automated Nikon microscope and Yokogawa spinning 
disk confocal, but other microscope platforms can also be used. A spinning disk confocal 
microscope is essential in order to minimize cellular toxicity that occurs with excessive 
illumination while enabling fast and efficient imaging. Further, confocal imaging minimizes 
fluorescence from outside the focal plane and improves accuracy. An automated stage is 
required to image multiple PVs per experiment.
Materials
60× 1.4 NA oil immersion objective (Cat# MRD01605) on a motorized and fully 
automated inverted microscope-motorized TiE controlled by Elements (Nikon 
Instruments, Melville, NY)
Andor iXon 887 EM-CCD attached to a CSU10 spinning disk confocal (Yokogawa, 
Japan) with a MLC-400 Agilent laser launch with 488 and 561 nm lasers (Agilent, 
CA) and Lambda 10-3 controlled filter wheel (Sutter Instruments, Novato, CA) fitted 
with emission filters ET525/36m and ET605/70m (Chroma Technologies, Bellows 
Falls, VT) attached to the above microscope.
Live cell chamber, humidified and equilibrated to 37.1°C, 5% CO2 (Support Protocol 
4).
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HeLa cells infected with mCherry-Coxiella and plated on Ibidi μ-Slides (Support 
Protocols 1 and 3). If desired, HeLa cells can be treated with siRNA (Support 
Protocol 2) prior to Coxiella infection.
Complete culture media (RPMI with 10% fetal bovine serum)
200 μL pipette and sterile tips
2 mg/ml Alexa488-labeled dextran (10,000 molecular weight; D22910, 
ThermoFisher Scientific) in culture media (see reagents).
1. Warm culture media and dextran in culture media to 37°C.
This is critical to avoid flexing of the plastic that occur with temperature 
fluctuations.
2. In one channel of the μ-Slide, use mCherry-Coxiella to identify PVs and mark 
positions using microscope software.
To maximize the number of imaged PVs and avoid issues with oil in 
moving between channels, only one channel should be imaged at a time.
3. Determine the timepoints for sampling, total chase time, z-sample (number of z-
stacks and size of slices), and camera settings (e.g., exposure time) for both 
Alexa488-dextran and mCherry-Coxiella. Setup the imaging experiment in the 
microscope software with the determined settings. In Elements, these setting are 
set within the “nd Acquisition” tool.
Set the timepoints to allow for the time it takes to collect the z-stacks at 
all the positions identified. Timepoints should be kept constant between 
experiments to facilitate comparisons.
Ideally, z-stacks will be sampled at or near the Nyquist criteria (~0.130 
μm for this 60× 1.4 NA oil immersion objective used here, https://svi.nl/
Nyquistcalculator). We typically sample at ~0.3 μm. Following the 
washes, the z-stack range and camera setting can be confirmed and 
adjusted as required as the dish may be move slightly during the 
washing steps.
In determining camera settings, it is imperative that there are no 
saturated pixels within the PV. If this happens, pixel intensities will be 
artificially cutoff and the mean intensities will be under-estimated.
4. With a 200 μL pipette, carefully remove 120 μL from the far channel. To the near 
channel, add 120 μL of pre-warmed (37°C) Alexa488-dextran (2 mg/ml in 
culture media) and simultaneously start a timer. Incubate for 10 minutes.
HeLa cells are cultured on the channel slides in 150 μL. Removing 120 
μL will leave 30 μL in the culturing channel. Be careful to not disturb 
the Ibidi slide.
5. After ten minutes, use a 200 μL pipette to remove 120 μL of the labeling media 
from the far reservoir. Add 120 μL of 37°C culture media to the near reservoir, 
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allow the media to reach the far reservoir and remove 120 μL from the far 
reservoir.
6. Repeat at least 4 more times.
Five washes should be sufficient to remove uninternalized Alexa488-
dextran. More washes may be performed if residual green fluorescence 
is observed in the extracellular media.
7. Check the PV positions, the z-stack range and the camera settings identified in 
step 1. Record this time as “dead-time.”
Typically, the ‘dead-time’ is 3–4 minutes. When comparing between 
experiments it is imperative that this is consistent to ensure comparable 
trafficking times.
8. Begin imaging experiment using the settings set in step 1 or as adjusted in step 7. 
The first set of captured images represents the “initial” intensity.
SUPPORT PROTOCOL 1. Infection of HeLa cells with Coxiella
Coxiella readily infects a wide range of cell types, including epithelial cells and 
macrophages. Once internalized by the host cell, Coxiella-containing phagosomes can 
undergo homotypic fusion. As it has not been established if vacuole maturation proceeds 
differently in cells infected with multiple bacteria, this protocol uses infection conditions 
that have been optimized for ~1 bacterium per cell, with 30–40% of the cells being infected. 
The infection conditions are determined empirically for each bacteria stock, cell type, and 
culture vessel being used. For basic culturing of HeLa cells, see Current Protocols in 
Microbiology Unit 11A.2, “Sphingolipid trafficking and purification in Chlamydia 
trachomatis-infected cells” (Elizabeth R. Moore, 2013). For preparation of Coxiella Nine 
Mile II (NMII) stocks from Vero cells, see Cockrell et al (Cockrell, Beare, Fischer, Howe, & 
Heinzen, 2008). These steps should be done in a biosafety cabinet with sterile reagents.
Materials
Trypsinized HeLa cells
Hemacytometer
Tissue culture scope with 10X objective
Complete growth medium (RPMI containing 10% FBS)
24 well tissue culture plate
Coxiella burnetii stock [Copy Editor: Please ask the author to clarify… Is this labeled 
with mCherry? If so, where can you obtain this? Or, if you have to label it yourself, 
how is that done? Furthermore, it seems that mCherry should be mentioned in the 
protocol introduction.]
Sterile 1X PBS (phosphate buffer saline)
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1. Count HeLa cells with hemacytometer (Appendix 4A) and dilute to 1×105 
cells/ml in complete growth medium. Add 500 μL cells per well of 24 well plate, 
for a final number of 5×104 cells per well. Let adhere 4–6 hours.
Unless over-trypsinized, HeLa cells should attach and spread out within 
4 hours. The cells can also be left overnight; however, cell growth must 
be considered when calculating the number of bacteria to use during the 
infection. This can be determined by trypsinizing and determining cell 
number in several extra wells right before the infection.
2. In complete growth medium in a sterile 15 ml conical, dilute Coxiella stock to 
4×107 bacteria/mL. The final number of bacteria being added is 200 per cell.
Vortex the bacteria stock well before removing an aliquot, making sure 
to look for clumps. After adding to growth medium, vortex for another 
30–60 seconds.
3. Remove media from well and replace with 250 μL of diluted bacteria.
Incubating in a smaller volume increases the efficiency of uptake.
4. Incubate at 37°C, 5% CO2 for 1 hour.
5. Wash wells extensively with sterile PBS.
Coxiella NMII bacteria are hydrophobic, and tend to stick to the plastic. 
To remove uninternalized bacteria, it may be necessary to wash with 15 
– 20 exchanges of PBS. To ensure that the cells do not dry out, wash 
wells one at a time, always leaving enough PBS to just cover the cells.
6. Replace with 500 μL complete growth media.
7. Incubate at 37°C, 5% CO2.
SUPPORT PROTOCOL 2: Transfection of HeLa cells with siRNA
Transfection is a method to deliver nucleic acids into cells, typically using a lipid carrier. 
During a “forward” transfection, cells are seeded onto plates and transfected with nucleic 
acid-lipid complexes the following day. A “reverse” transfection involves adding the nucleic 
acid-lipid complexes while the cells are being seeded. Reverse transfection not only saves 
time but also often increases knockdown efficiency. This protocol uses reverse transfection 
to deplete cells of the protein of interest using small-interfering RNA (siRNA) with 
Dharmacon Smartpool siRNA and Dharmafect transfection reagent (GE Healthcare). These 
steps should be done in a biosafety cabinet with sterile reagents.
Materials
Sterile 1.5 ml microcentrifuge tubes
Serum-free RPMI
Dharmafect 1 (GE Healthcare)
Control (e.g., non-targeting) and experimental siRNA at 20 μM stock concentration
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24 well tissue culture plate
Trypsin
T25 or T75 of HeLa cells, depending on the number of wells to be transfected
Hemacytometer
Tissue culture scope with 10X objective
Antibiotic-free complete growth medium (RPMI with 10% fetal bovine serum)
1. Make a master mix of diluted Dharmafect in a 1.5 ml microcentrifuge tube. For 
each well of a 24 well plate, add 0.62 μL Dharmafect to 130 μL serum-free 
RPMI.
Serum-free media is required to form siRNA-lipid complexes. To keep 
the lipid from sticking to the tube walls, pipet the Dharmafect directly 
into the media.
2. Add stock siRNA to diluted Dharmafect master mix to a final concentration of 
50 nM. For example, for each well add 1.6 μl stock siRNA (20 μM) to 130 μL 
diluted Dharmafect master mix. Vortex briefly to mix.
Make a mastermix of siRNA if doing multiple wells.
3. To each well of a 24 well plate, transfer 125 μL of siRNA-lipid mix.
4. Incubate siRNA-Dharmafect mix 30 minutes at room temperature.
5. While incubating, trypsinize HeLa cells, count with a hemacytometer, and dilute 
to 5×104 cells/ml in antibiotic-free complete growth media.
For best transfection efficiency, use cells in log-phase and less than 20 
passages. The use of antibiotics will decrease efficiency and may cause 
toxicity. For basic culturing of HeLa cells, see Current Protocols in 
Microbiology Unit 11A.2, “Sphingolipid trafficking and purification in 
Chlamydia trachomatis-infected cells” (Elizabeth R. Moore, 2013).
6. Following the 30 minute incubation of siRNA-lipid mix, add 500 μL of diluted 
cells to each well, pipetting up and down several times to mix.
7. Transfer cultures to a 37°C, 5% CO2 incubator for desired amount of time.
For each targeted protein, the amount of time required for efficient 
knockdown should be determined, along with how the long the 
knockdown lasts and if Coxiella infection affects knockdown stability. It 
may be necessary to transfect a second time to achieve knockdown. In 
this case, we typically re-transfect with siRNA after infection with 
Coxiella.
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SUPPORT PROTOCOL 3. Replating infected cells from 24 well plate onto 
ibidi μ-slides
Cells treated with siRNA and infected with Coxiella are replated onto imaging dishes 24 hrs 
before imaging. Slides or dishes from Ibidi (Fitchburg, WI) are used because of their: 1) low 
volume and surface area, meaning fewer cells and less dextran are required; 2) optical grade 
plastic that is amenable to cell attachment while being compatible with high resolution 
fluorescence microscopy; 3) standard slide size. Here we describe plating onto the Ibidi μ-
Slide VI0.1, which has six channels to facilitate multiple samples in one experiment. When 
using for the first time, consult the manufacturer’s product information sheet for tips on 
handling and culturing cells in Ibidi μ-Slides.
Materials
Infected HeLa cells in a 24 well plate from Supporting Protocol 1
Sterile 15 ml conical tubes
Complete growth medium (RPMI containing 10% FBS)
Trypsin
Swinging bucket centrifuge
Hemacytometer
Tissue culture scope with 10X objective
200 μL pipetter with sterile tips
μ-Slide VI0.1 (catalog number 80296, Ibidi, Fitchburg, WI)
1. Transfer 10 mL complete growth medium to a 15 mL conical tube.
2. Trypsinize cells in a single well with 150 μL trypsin, and transfer to the 15 mL 
conical tube with complete growth medium.
It is often necessary to pool multiple wells of a 24 well plate, depending 
on how many cells are needed to plate the desired number of channels. 
To concentrate cells for plating onto the Ibidi μ-slide, the cells most 
often need to be spun down. This is because the trypsin must be diluted 
with 5 volumes of 10% RPMI to inactivate enzymatic activity and avoid 
killing the cells.
3. Centrifuge 250xg for 5 min.
4. Carefully remove the media, and resuspend in a small volume of complete 
growth medium (<500 μL).
5. Count cells with hemacytometer, and adjust volume to 2–3×105 cells/ml with 
complete growth medium.
6. Add 30 μL of resuspended cells to one channel of ibidi μ-slide.
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Consult the manufacturer’s product information sheet for tips on plating 
and removing bubbles.
7. Place in incubator at 37°C, 5% CO2 for ~2 hours to allow the cells to adhere.
Because Ibidi μ-Slides exchange gas through the bottom, make sure to 
incubate according to the instructions.
8. After the cells have adhered, add 120 μL of 10% RPMI to each channel. Remove 
bubbles if necessary, and place back in the incubator.
SUPPORT PROTOCOL 4. Setup of live cell imaging chamber
The objective in live-cell microscopy is to maintain a tissue culture model, such as HeLa 
cells, in their normal growth conditions while conducting experiments that are best followed 
using microscopy. It is essential that the temperature be stable at 37.1°C, as membrane and 
cytoskeletal dynamics can change dramatically with temperature. Temperature (37.1°C), 
CO2 (5%) and humidity are controlled using commercially available chambers that can be 
adapted to a wide variety of microscope stages and culture dishes. This protocol describes 
imaging of Ibidi μ-Slides using a slide adapter installed in the stage top incubator Bold Line 
from OkoLabs (Burlingame, CA). The temperature in the OkoLab chamber is regulated 
either by its own temperature or by an auxiliary thermistor that can be placed inside the 
chamber in a dish filled with water or media. We choose to use the auxiliary thermistor 
approach as we find the temperature at the dish cannot be maintained at 37.1°C by setting 
just the chamber temperature. In addition, an objective heater set to 37.1°C ensures the 
sample is not cooled by a room temperature objective.
Materials
Okolab Bold Line universal stage top incubator with CO2 module, objective heater 
and OkoTouch for control (H301 Bold Line, OkoLabs, Burlingame, CA)
Distilled water
2 well Ph+ imaging dish (80296, Ibidi, Fitchburg, WI)
μSlide VI0.1 (80666, Ibidi, Fitchburg, WI)
Type 37 Oil immersion fluid (Type 37, Cargille Laboratories)
1. Fill the gas humidification chamber with distilled water.
This step may be common to live cell stage-top incubators. Distilled 
water, as opposed to pure water (i.e., Milli-Q) is used to avoid corrosion 
of the thermistor.
2. To image Ibidi μ-Slides, install the two-position slide adapter (2xGS-M) for the 
OkoLab chamber and install on microscope.
When using the OkoLab chamber, select the slide insert (2xGS-M) in 
the stage setup menu on the OkoTouch controller
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3. Place a 2 well Ph+ imaging dish filled with distilled water in the live cell 
chamber and thread the thermistor into one of the wells and under the inset 
plastic.
The cap for the 2 well Ph+ can be used to secure the thermistor in place. 
The distilled water may be preheated to accelerate the equilibration of 
the imaging chamber.
4. Install objective heater on 60× 1.4 NA oil immersion objective (MRD01605, 
Nikon Instruments, Melville, NY) and turn objective heater on and set to 37.1°C.
5. Place a μ-Slide VI0.1 with water in the chambers in the live cell chamber, and 
contact the objective with 37.1°C immersion oil (Type 37, Cargille Laboratories).
6. Run calibration routines for the temperature control. OkoLab touch provides 
access to calibration when selecting different control approaches or stage inserts 
under the “Settings” menu. Calibration may take 1–2 hours with the OkoLab 
Bold Line.
This step may be skipped if a recent calibration is valid for a given room 
temperature. We find it beneficial to work with building engineers to 
minimize room temperature fluctuations and ensure that appropriate 
cooling capacity is available in the room.
7. Set the humidity to 75% and temperature to 37.1°C and allow the chamber to 
equilibrate.
The temperature and humidity progress may be followed graphically on 
the OkoLab Touch and can take up to an hour.
SUPPORT PROTOCOL 5. Analysis of trafficking time course
The experimental data is analyzed using the open source imaging analysis software FIJI (4), 
and plotted with the graphing software Prism (GraphPad, San Diego, CA). The microscope 
software (i.e., Nikon Elements) records an annotated dataset with metadata that should be 
archived and backed-up for future reference. FIJI has the basic tools for quantitative analysis 
and can open most proprietary software formats via Bio-Formats (Linkert et al., 2010). As 
such, this protocol is relevant if data is collected on a platform other than Nikon Elements.
Materials
FIJI, Version 2.0.0-rc-59/1.51j with Java 8 installed for your computer platform 
(http://imagej.net/Downloads)
Digital datasets from microscope
Excel (Microsoft, Redmond, WA) or other spreadsheet software
Prism (GraphPad, San Diego, CA) or other graphing software
NOTE: This protocol is demonstrated in Video1.mp4.
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1. Open dataset in FIJI: “File” -> “Import” -> ”Bio-Formats” and in the “Bio-
Formats” interface select “HyperStack” from the “View stack with” option.
If the digital dataset contains many image datasets, such as multiple 
cells or stage positions, select each one you wish to open in the “Bio-
Formats” interface.
2. Separate the imaging channels: “Image” -> “Color” -> “Split Channels”.
3. Select the channel that contains the fluorescent dextran by clicking on the 
relevant window.
4. Perform a background subtraction: “Process” -> “Subtract Background…” with a 
radius of 50 pixels and process all images in stack when asked by the “Process 
Stack?” dialog window.
This pixel radius is a compromise between the smallest and largest PVs 
that may be encountered under these infection conditions at 3 days post 
infection. If the experiment is done at different times post-infection, 
when the PVs are significantly smaller or larger, this may need to be 
adjusted.
5. Sum all the z-stack slices: “Image” -> “Stacks” -> “Z-Project…” select “Sum 
Slices” and check “All time frames.”
Stacks are summed to avoid introducing unintended sampling bias 
which could be introduced by selecting a single z-slice.
6. Open “Analyze” -> “Set Measurements…” and select “Mean gray value”, 
“Area” and “Display Label”.
The Label field recorded in the “Results” table will include the 
timepoint following the final colon.
7. Move to the first timepoint by dragging the slider at the bottom of the image 
window all the way to the left. Open “Analyze” -> “Tools” and select “ROI 
Manager…”
8. Make a circle selection with a diameter of at least 20 pixels inside the Coxiella 
PV but preferably not overlapping Coxiella and add the circle selection to the 
“ROI Manager” by selecting “Add” in the “ROI Manager” window.
By adding the selection to the “ROI Manager” it can be recalled later by 
clicking on the selection in the “ROI Manager”, if the selection is 
removed accidentally. Further, a selection may be recalled from the 
“ROI Manager” on additional datasets to maintain consistency in the 
area measured.
9. Record the fluorescent intensity in the circle selection by pressing the ‘m’ key. 
This is the “Initial” average intensity.
NOTE: The PV may be labeled overnight with a spectrally non-
overlapping labeled dextran (e.g. Alexa647) to aid in selection of an 
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area inside the PV or the entire PV. The circle ROI should only need to 
be moved as the cell moves during the experiment.
10. Move to the next time point. Move circle selection to inside the PV (if required) 
and record the value by pressing the “m” key. Repeat for every time-point.
11. Copy the results from the FIJI “Results” table and paste into an Excel 
spreadsheet by using the right-click menu on the “Results” table or the “Edit” 
menu when selecting the “Results” table.
12. The fold change in intensity is calculated by dividing the average intensity 
(“mean gray value” at each timepoint by the “Initial” average intensity.
This assumes the volume of the PV does not change dramatically over 
the time course. If this a concern, the PV may be labeled overnight with 
a spectrally non-overlapping labeled dextran as mentioned above to 
enable measurement of the entire PV volume at every time-point.
13. Repeat for additional PVs and plot the fold change in Prism as column data for a 
given treatment condition. Statistical test such as t-test or ANOVA may be 
performed as appropriate.
REAGENTS AND SOLUTIONS
Dextran stock solution
Resuspend lyophilized Alexa488-dextran (D22910, ThermoFisher Scientific) at 10 mg/ml in 
sterile 1X PBS. Make 100 μl aliquots and store at −20°C, protected from light. To make the 
working stock immediately prior to live cell imaging, dilute to 2 mg/ml in 10% RPMI and 
vortex well. Centrifuge at 12,000xg for 2 minutes to pellet insoluble material. Transfer 
supernatant to a new sterile microcentrifuge tube.
COMMENTARY
Background Information
An obligate intracellular pathogen, Coxiella first targets alveolar macrophages during natural 
infection, but can infect a wide range of cells (Khavkin & Tabibzadeh, 1988; Stein et al., 
2005; Voth & Heinzen, 2007). Following phagocytosis by a host cell, the Coxiella-
containing phagosome matures through the endocytic pathway into an acidic and hydrolytic 
phagolysosome. Approximately 24–48 hours after host cell internalization, the Coxiella 
parasitophorous vacuole (PV) expands, forming a mature PV that is large, dynamic, and 
highly fusogenic with endosomes, lysosomes, and autophagosomes (Voth & Heinzen, 2007). 
Coxiella extensively modifies the PV through insertion of bacterial proteins into the 
phagosome membrane, as well as recruitment of host cell proteins. Host vesicular trafficking 
pathways are known to be manipulated by the Coxiella T4BSS, which secretes bacterial 
proteins across the PV membrane and into the host cytosol.
While interactions between the PV and host endocytic trafficking pathways are essential for 
PV formation, only recently have some of the host cell factors been identified and described. 
Winfree and Gilk Page 11
Curr Protoc Microbiol. Author manuscript; available in PMC 2018 August 11.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
The small GTPases Rab1b, Rab5, and Rab7 are found on the PV, with siRNA knockdowns 
or overexpression of dominant negatives preventing PV formation (Beron, Gutierrez, 
Rabinovitch, & Colombo, 2002; Campoy, Zoppino, & Colombo, 2011; McDonough et al., 
2013; Romano, Gutierrez, Beron, Rabinovitch, & Colombo, 2007). Depletion of clathrin or 
the clathrin-adaptor protein AP2 also blocks PV expansion (Larson, Beare, Howe, & 
Heinzen, 2013), and the lysosomal membrane proteins LAMP-1 and LAMP-2 increase the 
rate of endosome fusion (Schulze-Luehrmann et al., 2016). The endocytic SNARES 
syntaxin-17 and VAMP7 have also emerged as a critical component of PV formation 
(Campoy, Mansilla, & Colombo, 2013; McDonough et al., 2013).
Several approaches have been used to demonstrate heterotypic fusion between host vesicular 
trafficking pathways and the PV. The most common approach is measuring PV size, as the 
amount of fusion is thought to directly relate to formation and maintenance of the large PV 
(Larson et al., 2013; Romano et al., 2007). A second approach is determining the percentage 
of PVs with host vesicular markers, for example lysosomal cathepsin D (Romano et al., 
2007), assuming that these proteins are delivered directly through fusion. Both of these 
approaches are simple and do not require specialized techniques; however, changes in PV 
size or marker acquisition could be due to factors other than PV-endosome fusion.
A third method examines delivery of vesicular cargo into the PV lumen, which is a direct 
measure of fusion between the PV and cargo-carrying vesicles. Both fluorescent dextran and 
BSA are used as fluid-phase endosome markers (Campoy et al., 2013; Campoy et al., 2011; 
Justis et al., 2017; Mulye, Samanta, Winfree, Heinzen, & Gilk, 2017), while fluorescent 
heat-inactivated Staphylococcus aureus and latex beads mark phagosomes (Colonne et al., 
2016; Schulze-Luehrmann et al., 2016). Traditionally, cargo delivery to the PV has been 
quantitated by determining the percentage of cargo-positive PVs, and has been used almost 
exclusively in fixed cells. While straightforward, quantitation is based strictly on the 
presence or absence of the marker, and cannot account for variations in fusion. As a result, 
more subtle phenotypes can be easily missed. This protocol quantitates the change in PV 
dextran fluorescence over time using live cell imaging, providing a continuous measure of 
fusion. By sampling at regular intervals during the timecourse, this approach can also 
identify conditions where the rate of fusion may vary with time, even if the amount of fusion 
is of the same final magnitude. The major disadvantage of this approach is that it requires a 
sophisticated spinning disk confocal microscope platform with live cell capabilities. Further, 
technical precision is critical, as the assay is very sensitive to timing precision and 
consistency between experiments.
Critical Parameters
Working with Coxiella—Avirulent Coxiella Nine Mile II (NMII) must be handled at 
biosafety level 2 (BSL2). Aseptic technique is required, as antibiotics traditionally used in 
cell culture (e.g., penicillin, streptomycin) inhibit Coxiella growth. Historically, Coxiella 
stocks were prepared from aged cultures in Vero cells, which allows for isolation of the 
stable small cell variant (SCV) of Coxiella. Recently, the development of an axenic media 
allows for growth in the absence of host cells (Omsland, 2012). For experiments that only 
use wild-type bacteria or bacteria that do not have a growth phenotype in cells (e.g., Coxiella 
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expressing mCherry), we use Coxiella isolated from Vero cells infected for 28 days 
(Cockrell et al., 2008). We find the yield from Vero cells to be significantly higher than 
axenic media, enabling the same stock to be used for months to years. While Coxiella stocks 
stored at −80°C in 10% DMSO appear to be stable for multiple freeze/thaws, it is a good 
idea to make single-use aliquots to eliminate the possibility of viability loss.
Working with eukaryotic cells—HeLa cells should be handled at BSL2 level using 
aseptic techniques. As with all eukaryotic cells, it is critical that HeLa cells are cultured 
under conditions that maintain optimum health. For example, cells should be split every 2–3 
days, kept sub-confluent, and used for a limited number of passages (typically 20) as HeLa 
cells acquire genetic alterations the longer they are kept under continuous culture. Stocks 
and cultures should be checked regularly for mycoplasma infection. A sudden loss in 
transfection or knockdown efficiency can often be traced to the cell health.
Timing of live cell imaging—Live cell imaging experiments are often limited by the 
frequency with which imaging can be performed for a given number of fields or stage 
positions. It is imperative that the speed of the microscope and its peripherals is sufficient to 
accomplish the required imaging between the desired timepoints. This will often limit the 
number of fields or cells that can be imaged, and can require multiple experiments to image 
a statistically significant number of PVs. A strict measurement of pulse time and dead time 
is required to enable comparisons between experiments.
Anticipated Results
This assay has proven to be sensitive and precise. In HeLa cells over a 30 minute time 
course, we have measured up to a 2 fold change in fluorescence at 3 days post infection. 
Importantly, we found a statistically significant 20% change in fusion between control and 
experimental conditions, indicating this assay can be used to measure subtle changes in PV-
endosome fusion.
Time Considerations
The significant variables in total experimental time include siRNA knockdown and Coxiella 
infection. Our typical experiment, examining trafficking at 3 days post infection, is five days 
long: siRNA transfection at day 1, Coxiella infection at day 2, replating onto Ibidi μ-Slides 
on day 4, and live cell imaging on day 5. In every experimental run of the basic protocol, 
nine to ten PVs should be imaged. A single run will take approximately 45 minutes and thus 
over a half day, accounting for live-cell setup and equilibration, 40–60 PVs can be measured. 
With properly staggered infected cells, a complete set of three experiments, with controls 
and experimental conditions, can be completed within two weeks.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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